theme-sticky-logo-alt
Please assign a Header Menu.
Artificial Intelligence (AI)
NeuralTrust Launches AI Agent Security Platform
As enterprises move from AI assistants toward autonomous AI agents capable of executing tasks, accessing data, and interacting with business systems, security teams face a new challenge: protecting dynamic AI behavior rather than individual applications. NeuralTrust has launched an AI agent runtime security platform designed to protect multiple AI agents through a single security gateway,... Read More
Ambition Launches AI Skills for Sales Teams
Sales performance platform Ambition has launched Agent Skills, a new AI workflow library designed to automate core revenue management processes including coaching preparation, pipeline reviews, forecasting analysis, and performance evaluations. The company says the new capability aims to help sales organizations scale consistent coaching practices while giving executives, managers, and sales representatives faster access to... Read More
CollectivIQ AI Consensus Platform Improves Accuracy
As enterprises increasingly rely on artificial intelligence for research, analysis, and strategic decisions, accuracy and trustworthiness have become major challenges. CollectivIQ, an AI consensus platform for business intelligence, has released benchmark results showing its multi-model reasoning architecture can outperform individual large language models (LLMs) by combining responses from multiple AI systems, including ChatGPT, Gemini, Claude,... Read More
GenScript Connects AI Drug Design With Validation
Artificial intelligence is accelerating the pace of molecular discovery, enabling researchers to generate thousands of potential drug candidates in the time traditional methods required to design only a handful. However, transforming AI-generated designs into viable therapies still depends on experimental validation. GenScript Biotech Corporation and Tamarind Bio are addressing this challenge through a strategic partnership... Read More
Olio Labs Uses AI to Predict Drug Trial Outcomes
Artificial intelligence is increasingly being used to address one of drug development’s biggest challenges: predicting whether promising therapies will succeed in humans. Olio Labs has announced research showing that its AI-powered preclinical platform can forecast potential clinical outcomes, including gastrointestinal side effects, cardiac toxicity, neuropsychiatric effects, and long-term weight changes, using advanced behavioral analysis of... Read More
Cephia Names Mike McAuliffe as AI Sensor CEO
AI-native imaging company Cephia has appointed semiconductor and computer vision executive Mike McAuliffe as President and Chief Executive Officer, signaling a new phase of commercialization for its next-generation image sensor technology. The leadership move comes as demand grows for compact AI perception systems powering physical AI applications across robotics, automotive, drones, healthcare, satellites, and industrial... Read More
AI Reshapes Business Risk and Investment Strategy
Artificial intelligence and autonomous technologies are moving from experimental concepts into real-world systems that could reshape competitive markets, according to a new analysis from Egan-Jones Ratings Company. The report examines how advances in AI, automation, and autonomous decision-making are challenging traditional business models while creating new considerations for institutional investors, credit analysts, and enterprise risk... Read More
AI Search Is Reshaping Brand Consistency
The rise of generative AI search is transforming how brands are discovered online. Instead of directing users to a list of websites, AI-powered answer engines increasingly synthesize information into direct responses, making brand consistency a strategic requirement rather than simply a marketing best practice. According to creative studio della, organizations must now ensure that every... Read More
Insilico Advances AI-Designed Eye Disease Drug
Generative AI is continuing to reshape drug discovery as biotechnology companies use machine learning to shorten development timelines and identify novel therapeutic targets. Insilico Medicine has announced the nomination of ISM9077 as its latest preclinical candidate, an AI-designed small-molecule therapy aimed at treating multiple inflammatory eye diseases while also supporting broader research into aging and... Read More
15 49.0138 8.38624 both both 1 3000 1 1 horizontal https://techedgeai.com 300 true 0 1
SUBSCRIBE

Sign up today for exclusive

insights and updates.

Newsletter Signup

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Techedge AI | Latest AI & Technology News Today will use the information you provide on this form to be in touch with you and to provide updates and marketing.